Saroja Pharma Indus Ind L Stock Price Today (NSE: SAROJA)
Fundamental Score
Saroja Pharma Indus Ind L Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Saroja Pharma Indus Ind L share price today is ₹32.50, up +0.00% on NSE/BSE as of 19 June 2026. Saroja Pharma Indus Ind L (SAROJA) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹16.89 (Cr). The 52-week high for SAROJA share price is ₹60.00 and the 52-week low is ₹28.15. At a P/E ratio of 13.30x, SAROJA is currently trading below its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of 6.79% and a debt-to-equity ratio of 0.65.
Saroja Pharma Indus Ind L Share Price Chart — NSE/BSE Historical Performance
Saroja Pharma Indus Ind L share price chart: -1.07% return over the past month. 52-week high ₹60.00, 52-week low ₹28.15.
Saroja Pharma Indus Ind L — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹32.50 | ₹32.50 | ₹32.00 | ₹32.50 | 4.80K (Cr) | |
| ₹32.50 | ₹32.50 | ₹32.50 | ₹32.50 | 1.60K (Cr) | |
| ₹33.00 | ₹33.00 | ₹33.00 | ₹33.00 | 1.60K (Cr) | |
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | 3.20K (Cr) | |
| ₹29.40 | ₹29.40 | ₹29.40 | ₹29.40 | 6.40K (Cr) | |
| ₹29.35 | ₹29.35 | ₹29.35 | ₹29.35 | 1.60K (Cr) | |
| ₹28.15 | ₹28.15 | ₹28.15 | ₹28.15 | 3.20K (Cr) | |
| ₹35.00 | ₹35.00 | ₹35.00 | ₹35.00 | 1.60K (Cr) | |
| ₹36.05 | ₹36.05 | ₹36.05 | ₹36.05 | 3.20K (Cr) | |
| ₹35.80 | ₹36.00 | ₹35.80 | ₹36.00 | 3.20K (Cr) |
Saroja Pharma Indus Ind L — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹32.50 | ₹32.50 | ₹32.00 | ₹32.50 | +0.00% | |
| ₹32.50 | ₹32.50 | ₹32.50 | ₹32.50 | +0.00% | |
| ₹29.40 | ₹33.00 | ₹29.40 | ₹33.00 | +12.24% | |
| ₹28.15 | ₹29.35 | ₹28.15 | ₹29.35 | +4.26% | |
| ₹35.80 | ₹36.05 | ₹35.00 | ₹35.00 | -2.23% | |
| ₹39.20 | ₹39.55 | ₹32.50 | ₹32.50 | -17.09% | |
| ₹42.00 | ₹43.05 | ₹39.20 | ₹40.00 | -4.76% | |
| ₹41.25 | ₹42.00 | ₹39.50 | ₹42.00 | +1.82% | |
| ₹45.00 | ₹48.00 | ₹40.70 | ₹42.70 | -5.11% | |
| ₹48.10 | ₹51.75 | ₹43.70 | ₹45.00 | -6.44% | |
| ₹35.80 | ₹60.00 | ₹35.80 | ₹47.85 | +33.66% | |
| ₹36.25 | ₹40.00 | ₹34.00 | ₹35.80 | -1.24% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Saroja Pharma Indus Ind L Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Saroja Pharma Indus Ind L Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SAROJA across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Attractive Valuation (P/E: 13.30 vs Industry: 29.20)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (67.65%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (106.28%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Balanced Promoter Holding (73.02%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Below-Average Return on Equity (6.79%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Margin Pressure Concerns (4.84%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Weak Interest Coverage (2.42x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-11.77 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Saroja Pharma Indus Ind L vs Specialty Chemicals Peers
Peer Comparison - Specialty Chemicals
Compare Saroja Pharma Indus Ind L with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
41.7/100 | ₹32.50₹33 | ₹16.89₹16.89 | 13.30Average 13.3 Average | 6.79%Poor 6.79% Poor | 12.57%Average 12.57% Average | 0.65Good 0.7 Good | — — | — — | 0.00% | |
Pidilite Industries LimitedPidilite Indust... PIDILITIND • 500331 | 60.4/100 | ₹1480.70₹1481 | ₹149466.57₹149466.57 | 66.59Average 66.6 Average | 23.05%Excellent 23.05% Excellent | 29.84%Excellent 29.84% Excellent | 0.05Excellent 0.1 Excellent | 12.63%Good 12.63% Good | 12.49%Good 12.49% Good | 0.68% |
Gujarat Fluorochemicals LtdGujarat Fluoroc... FLUOROCHEM • 542812 | 51.5/100 | ₹3682.10₹3682 | ₹37241.99₹37241.99 | 54.77Average 54.8 Average | 8.29%Poor 8.29% Poor | 9.89%Poor 9.89% Poor | 0.23Excellent 0.2 Excellent | 21.05%Excellent 21.05% Excellent | 12.69%Good 12.69% Good | 0.09% |
Navin Fluorine International LtdNavin Fluorine ... NAVINFLUOR • 532504 | 40.6/100 | ₹7244.50₹7245 | ₹29462.02₹29462.02 | 66.34Average 66.3 Average | 11.52%Average 11.52% Average | 11.68%Average 11.68% Average | 0.33Excellent 0.3 Excellent | -6.59%Poor -6.59% Poor | 17.22%Excellent 17.22% Excellent | 0.21% |
Deepak Nitrite LtdDeepak Nitrite ... DEEPAKNTR • 506401 | 40.2/100 | ₹1714.80₹1715 | ₹21083.64₹21083.64 | 39.67Average 39.7 Average | 13.36%Average 13.36% Average | 16.28%Good 16.28% Good | 0.23Excellent 0.2 Excellent | 2.02%Average 2.02% Average | 14.38%Good 14.38% Good | 0.49% |
BASF India LtdBASF India Ltd... BASF • 500042 | 52/100 | ₹3430.20₹3430 | ₹17807.40₹17807.40 | 46.29Average 46.3 Average | 13.73%Average 13.73% Average | 18.02%Good 18.02% Good | 0.04Excellent 0.0 Excellent | 57.98%Excellent 57.98% Excellent | 14.83%Good 14.83% Good | 0.49% |
Atul LtdAtul Ltd... ATUL • 500027 | 50.5/100 | ₹7002.50₹7003 | ₹17066.13₹17066.13 | 31.47Average 31.5 Average | 9.10%Poor 9.10% Poor | 12.81%Average 12.81% Average | 0.03Excellent 0.0 Excellent | -5.82%Poor -5.82% Poor | 6.41%Good 6.41% Good | 0.43% |
Vinati Organics LtdVinati Organics... VINATIORGA • 524200 | 57.2/100 | ₹1325.10₹1325 | ₹16256.72₹16256.72 | 34.97Average 35.0 Average | 15.75%Good 15.75% Good | 20.61%Excellent 20.61% Excellent | 0.00Excellent 0.0 Excellent | 4.46%Average 4.46% Average | 16.92%Excellent 16.92% Excellent | 0.48% |
Anupam Rasayan India LtdAnupam Rasayan ... ANURAS • 543275 | 37.5/100 | ₹1368.00₹1368 | ₹14036.52₹14036.52 | 92.84Average 92.8 Average | 3.32%Poor 3.32% Poor | 7.33%Poor 7.33% Poor | 0.38Excellent 0.4 Excellent | 11.97%Good 11.97% Good | 22.13%Excellent 22.13% Excellent | 0.06% |
Aarti Industries LtdAarti Industrie... AARTIIND • 524208 | 41.9/100 | ₹500.75₹501 | ₹13796.68₹13796.68 | 51.29Average 51.3 Average | 6.03%Poor 6.03% Poor | 6.32%Poor 6.32% Poor | 0.70Good 0.7 Good | -9.09%Poor -9.09% Poor | 11.68%Good 11.68% Good | 0.26% |
Fine Organic Industries LtdFine Organic In... FINEORG • 541557 | 60.5/100 | ₹4677.30₹4677 | ₹13359.76₹13359.76 | 33.38Average 33.4 Average | 19.47%Good 19.47% Good | 26.39%Excellent 26.39% Excellent | 0.01Excellent 0.0 Excellent | 20.04%Excellent 20.04% Excellent | 16.93%Excellent 16.93% Excellent | 0.25% |
Top Specialty Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Pidilite Industries Limited share price149466.57 Cr
- Gujarat Fluorochemicals Ltd share price37241.99 Cr
- Navin Fluorine International Ltd share price29462.02 Cr
- Deepak Nitrite Ltd share price21083.64 Cr
- BASF India Ltd share price17807.40 Cr
Saroja Pharma Indus Ind L PE Ratio History
Historical price-to-earnings ratio for SAROJA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2023 | ₹2.64 | ₹53.00 | 20.1x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Saroja Pharma Indus Ind L Quarterly Performance
Latest quarterly metrics for SAROJA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
106.28%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
67.65%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Saroja Pharma Indus Ind L Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SAROJA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Saroja Pharma Indus Ind L Financial Statements
Annual income statement, balance sheet and cash flow for Saroja Pharma Indus Ind L (SAROJA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Saroja Pharma Indus Ind L
About SAROJA (Saroja Pharma Indus Ind L)
Saroja Pharma Indus Ind L (SAROJA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Specialty Chemicals sector w...ith a current market capitalisation of ₹16.89 (Cr). Saroja Pharma Indus Ind L has delivered a Return on Equity (ROE) of 6.79% and a ROCE of 12.57%. The debt-to-equity ratio stands at 0.65, reflecting the company's capital structure. Investors tracking SAROJA share price can monitor key metrics including P/E ratio, promoter holding of 73.02%, and quarterly earnings growth.
Company Details
SAROJA Share Price: Frequently Asked Questions
What is the current share price of Saroja Pharma Indus Ind L?
Saroja Pharma Indus Ind L (SAROJA) trades at ₹32.50 on NSE. Market cap ₹16.89 (Cr). Educational data only.
What is the P/E ratio of Saroja Pharma Indus Ind L?
Saroja Pharma Indus Ind L has a P/E of 13.30x vs industry average 29.20x.
What is the Bull Run score for Saroja Pharma Indus Ind L?
Saroja Pharma Indus Ind L has a Bull Run score of 41.7/100 based on 25+ financial parameters.
Does Saroja Pharma Indus Ind L pay dividends?
Saroja Pharma Indus Ind L has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Saroja Pharma Indus Ind L?
Saroja Pharma Indus Ind L has ROE of 6.79%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Saroja Pharma Indus Ind L?
Saroja Pharma Indus Ind L has debt-to-equity of 0.65.
Is Saroja Pharma Indus Ind L a good investment?
Bull Run gives Saroja Pharma Indus Ind L a score of 41.7/100. This is not investment advice — consult a SEBI-registered advisor.